Leak Risk Tied To Endologix Grafts Found In More Models, FDA Says
Executive Summary
A recent warning from the US agency ties two additional models of AFX endovascular grafts from Endologix Inc. to potentially fatal blood leaks. An earlier model of the devices, which are used to treat abdominal aortic aneurysms, was removed from the market last year over similar concerns.
You may also be interested in...
Bleeding Risk For Endologix AAA Grafts Reconfirmed
Postmarket monitoring continues to show a consistent risk of type III endoleaks in patients with Endologix AFX grafts.
Discontinued Endologix AAA Graft Device Singled Out In Updated FDA Alert
US FDA says that previously identified elevated risks of type III endoleaks from endovascular aneurysm repair systems appears to be linked to a specific, no-longer-sold device, Endogix's AFX with Strata system.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.